{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T21:49:36Z","timestamp":1771883376412,"version":"3.50.1"},"reference-count":13,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,1]]},"abstract":"<jats:sec>\n<jats:title>OBJECTIVE<\/jats:title>\n<jats:p>Relatively little is known about the safety and accuracy of catheter placement for oncolytic viral therapy in children with malignant brain tumors. Accordingly, this study combines data from two phase I clinical trials that employed viral immunotherapy across two institutions to describe the adverse event profile, safety, and accuracy associated with the stereotactic placement and subsequent removal of intratumoral catheters.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>METHODS<\/jats:title>\n<jats:p>Children with progressive\/recurrent supratentorial malignant tumors were enrolled in two clinical trials (NCT03043391 and NCT02457845) and treated with either the recombinant polio:rhinovirus (lerapolturev) or the genetically modified oncolytic herpesvirus (G207). Age, sex, race, tumor diagnosis, and tumor location were analyzed. Events related to the catheter placement or removal were categorized. A catheter that was either pulled back or could not be used was defined as \"misplaced.\" Neuronavigation software was used to analyze the accuracy of catheter placement for NCT03043391. Descriptive statistics were performed.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>RESULTS<\/jats:title>\n<jats:p>Nineteen patients were treated across the two completed trials with a total of 49 catheters. The mean \u00b1 SD (range) age was 14.1 \u00b1 3.6 (7\u201319) years. All tumors were grade 3 or 4 gliomas. Nonlobar catheter tip placement included the corpus callosum, thalamus, insula, and cingulate gyrus. Six of 19 patients (31.6%) had minor hemorrhage noted on CT; however, no patients were symptomatic and\/or required intervention related to these findings. One of 19 patients had a delayed CSF leak after catheter removal that required oversewing of the surgical site. No patients developed infection or a neurological deficit. In 7 patients with accuracy data, the mean \u00b1 SD distance of the planned trajectory (PT) to the catheter tip was 1.57 \u00b1 1.6 mm, the mean angle of the PT to the catheter was 2.43\u00b0 \u00b1 2.1\u00b0, and the greatest distance of PT to the catheter in the parallel plane was 1.54 \u00b1 1.5 mm. Three of 49 (6.1%) catheters were considered misplaced.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>CONCLUSIONS<\/jats:title>\n<jats:p>Although instances of minor hemorrhage were encountered, they were clinically asymptomatic. One of 49 catheters required intervention for a CSF leak. Congruent with previous studies in the literature, the stereotactic placement of catheters in these pediatric tumor patients was accurate with approximately 95% of catheters having been adequately placed.<\/jats:p>\n<\/jats:sec>","DOI":"10.3171\/2023.12.peds23404","type":"journal-article","created":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T02:04:45Z","timestamp":1705111485000},"page":"359-366","source":"Crossref","is-referenced-by-count":5,"title":["The safety and accuracy of intratumoral catheter placement to infuse viral immunotherapies in children with malignant brain tumors: a multi-institutional study"],"prefix":"10.3171","volume":"33","author":[{"given":"Ariana","family":"Barkley","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, University of New Mexico, Albuquerque, New Mexico;"},{"name":"Departments of Neurosurgery and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Butler","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Park","sequence":"additional","affiliation":[{"name":"School of Medicine, Duke University, Durham, North Carolina;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Friedman","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Landi","sequence":"additional","affiliation":[{"name":"Pediatrics, Duke University, Durham, North Carolina;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Ashley","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darell","family":"Bigner","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua D.","family":"Bernstock","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory K.","family":"Friedman","sequence":"additional","affiliation":[{"name":"Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas; and"},{"name":"Pediatrics, University of Alabama at Birmingham, Alabama;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Johnston","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric M.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"},{"name":"Department of Neurosurgery, University of Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"issue":"2","key":"b1","series-title":"N Engl J Med","first-page":"150","article-title":"Recurrent glioblastoma treated with recombinant poliovirus","volume":"379","author":"Desjardins A","year":"2018","unstructured":"Desjardins A, Gromeier M, Herndon JE II,  Recurrent glioblastoma treated with recombinant poliovirus. N Engl J Med. 2018;379(2):150\u2013161."},{"issue":"7","key":"b2","series-title":"Lancet Child Adolesc Health","first-page":"471","article-title":"Recombinant polio-rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial","volume":"7","author":"Thompson EM","year":"2023","unstructured":"Thompson EM, Landi D, Brown MC,  Recombinant polio-rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial. Lancet Child Adolesc Health. 2023;7(7):471\u2013478."},{"issue":"10","key":"b3","series-title":"Gene Ther","first-page":"867","article-title":"Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial","volume":"7","author":"Markert JM","year":"2000","unstructured":"Markert JM, Medlock MD, Rabkin SD,  Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial. Gene Ther. 2000;7(10):867\u2013874."},{"issue":"5","key":"b4","series-title":"Mol Ther","first-page":"1048","article-title":"A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responses","volume":"22","author":"Markert JM","year":"2014","unstructured":"Markert JM, Razdan SN, Kuo HC,  A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responses. Mol Ther. 2014;22(5):1048\u20131055."},{"issue":"1","key":"b5","series-title":"Mol Ther","first-page":"199","article-title":"Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM","volume":"17","author":"Markert JM","year":"2009","unstructured":"Markert JM, Liechty PG, Wang W,  Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM. Mol Ther. 2009;17(1):199\u2013207."},{"issue":"17","key":"b6","series-title":"N Engl J Med","first-page":"1613","article-title":"Oncolytic HSV-1 G207 immunovirotherapy for pediatric high-grade gliomas","volume":"384","author":"Friedman GK","year":"2021","unstructured":"Friedman GK, Johnston JM, Bag AK,  Oncolytic HSV-1 G207 immunovirotherapy for pediatric high-grade gliomas. N Engl J Med. 2021;384(17):1613\u20131622."},{"issue":"19-20","key":"b7","series-title":"Hum Gene Ther","first-page":"1132","article-title":"Design and rationale for first-in-human phase 1 immunovirotherapy clinical trial of oncolytic HSV G207 to treat malignant pediatric cerebellar brain tumors","volume":"31","author":"Bernstock JD","year":"2020","unstructured":"Bernstock JD, Bag AK, Fiveash J,  Design and rationale for first-in-human phase 1 immunovirotherapy clinical trial of oncolytic HSV G207 to treat malignant pediatric cerebellar brain tumors. Hum Gene Ther. 2020;31(19-20):1132\u20131139."},{"key":"b8","series-title":"World Neurosurg","first-page":"e1592","article-title":"Stereotactic placement of intratumoral catheters for continuous infusion delivery of herpes simplex virus -1 G207 in pediatric malignant supratentorial brain tumors","volume":"122","author":"Bernstock JD","year":"2019","unstructured":"Bernstock JD, Wright Z, Bag AK,  Stereotactic placement of intratumoral catheters for continuous infusion delivery of herpes simplex virus -1 G207 in pediatric malignant supratentorial brain tumors. World Neurosurg. 2019;122:e1592\u2013e1598."},{"issue":"26","key":"b9","series-title":"N Engl J Med","first-page":"2471","article-title":"Oncolytic DNX-2401 virus for pediatric diffuse intrinsic pontine glioma","volume":"386","author":"G\u00e1llego P\u00e9rez-Larraya J","year":"2022","unstructured":"G\u00e1llego P\u00e9rez-Larraya J, Garcia-Moure M, Labiano S,  Oncolytic DNX-2401 virus for pediatric diffuse intrinsic pontine glioma. N Engl J Med. 2022;386(26):2471\u20132481."},{"issue":"14","key":"b10","series-title":"J Clin Oncol","first-page":"1419","article-title":"Phase I study of DNX-2401 (Delta-24-RGD) oncolytic adenovirus: replication and immunotherapeutic effects in recurrent malignant glioma","volume":"36","author":"Lang FF","year":"2018","unstructured":"Lang FF, Conrad C, Gomez-Manzano C,  Phase I study of DNX-2401 (Delta-24-RGD) oncolytic adenovirus: replication and immunotherapeutic effects in recurrent malignant glioma. J Clin Oncol. 2018;36(14):1419\u20131427."},{"issue":"24","key":"b11","series-title":"Clin Cancer Res","first-page":"5419","article-title":"Safety and efficacy of intraventricular immunovirotherapy with oncolytic HSV-1 for CNS cancers","volume":"28","author":"Kang KD","year":"2022","unstructured":"Kang KD, Bernstock JD, Totsch SK,  Safety and efficacy of intraventricular immunovirotherapy with oncolytic HSV-1 for CNS cancers. Clin Cancer Res. 2022;28(24):5419\u20135430."},{"issue":"1","key":"b12","series-title":"Chin Neurosurg J","first-page":"40","article-title":"The risk factors of hemorrhage in stereotactic needle biopsy for brain lesions in a large cohort: 10 years of experience in a single center","volume":"8","author":"Li H","year":"2022","unstructured":"Li H, Zheng C, Rao W, Sun J, Yu X, Zhang J. The risk factors of hemorrhage in stereotactic needle biopsy for brain lesions in a large cohort: 10 years of experience in a single center. Chin Neurosurg J. 2022;8(1):40."},{"issue":"11","key":"b13","series-title":"Acta Neurochir (Wien)","first-page":"2011","article-title":"Contemporary frameless intracranial biopsy techniques: might variation in safety and efficacy be expected","volume":"157","author":"Verploegh IS","year":"2015","unstructured":"Verploegh IS, Volovici V, Haitsma IK,  Contemporary frameless intracranial biopsy techniques: might variation in safety and efficacy be expected? Acta Neurochir (Wien). 2015;157(11):2011\u20132016."}],"container-title":["Journal of Neurosurgery: Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/33\/4\/article-p359.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/33\/4\/article-p359.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/33\/4\/article-p359.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T13:04:49Z","timestamp":1733490289000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/33\/4\/article-p359.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,1]]},"references-count":13,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3171\/2023.12.peds23404","relation":{},"ISSN":["1933-0707","1933-0715"],"issn-type":[{"value":"1933-0707","type":"print"},{"value":"1933-0715","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,1]]}}}